Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Douglas RS et al. – Using a Delphi exercise, authors developed provisional core measures for assessing disease activity and severity in clinical trials of therapies for thyroid eye disease. These measures will be iteratively refined for use in multicenter clinical trials.

Related Articles

Can Autoimmunity Against Calsequestrin Explain the Eye and Eyelid Muscle Inflammation of Thyroid Eye Disease?
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09    Relevance Score: 82%

Thyroid Eye Disease: A Historical Perspective
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09    Relevance Score: 81%

Update on thyroid eye disease and management
Clinical Ophthalmology, 10/19/09    Relevance Score: 81%

Rituximab in the Treatment of Thyroid Eye Disease: Science Fiction
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09    Relevance Score: 79%

A Step Towards Individualized, Anatomy-Based Surgical Concepts for Orbital Decompression in Graves Orbitopathy
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09    Relevance Score: 78%

Today in Neuro-Ophthalmology...keeping you current

Thyroid Eye Disease: Pathogenesis and Treatment
Ophthalmologica, 12/01/09

Neurosyphilis With Unilateral Optic Tract Lesion Causing Homonymous Hemianopia
The Neurologist, 11/24/09

Timing of Corticosteroid Therapy is Critical to Prevent Retinal Ganglion Cell Loss in Experimental Optic Neuritis
Investigative Ophthalmology and Visual Science, 11/20/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address